Appili Therapeutics Inc. APLIF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score

23/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Appili Therapeutics Inc. (APLIF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 21/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

23/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

MOAT

46/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — APLIF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio15.70

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.02

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2017	$-0.06	$0.00	$-1.75M	-
2018	$-0.12	$0.00	$-3.98M	-
2019	$-0.14	$0.00	$-4.33M	-
2020	$-0.13	$199.11K	$-4.33M	-2175.2%
2021	$-0.24	$0.00	$-14.33M	-
2022	$-0.38	$1.39M	$-25.12M	-1806.2%
2023	$-0.08	$334.18K	$-9.24M	-2765.9%
2024	$-0.03	$827.41K	$-3.78M	-457%
2025	$-0.02	$100.44K	$-2.62M	-2613.1%